Adapalene (Differin Gel)
Third-generation retinoid normalizing follicular keratinization to fundamentally prevent comedone formation
About This Treatment
Adapalene (Differin Gel 0.1%) is a third-generation synthetic retinoid, insurance-covered for acne in Japan. Selectively binds RARβ/γ subtypes to normalize follicular keratinization and prevent comedone formation. Significantly less irritating than tretinoin with superior photostability. Rated highest recommendation (A) in Japanese Dermatological Association acne guidelines.
Mechanism of Action
Adapalene selectively binds RARβ/γ: ①regulates follicular keratinization to prevent abnormal cornification (comedolytic), ②inhibits AP-1 to suppress IL-1β/IL-6/TNF-α (anti-inflammatory), ③dissolves existing microcomedones preventing progression, ④modulates TLR2 expression. Low RARα binding explains reduced irritation vs tretinoin.
Indications
Expected Results
Comedone reduction starts at 2-4 weeks. At 12 weeks: 50-60% reduction in inflammatory lesions, 60-70% in non-inflammatory. 65% of patients prefer adapalene over tretinoin (less irritation). Synergistic with benzoyl peroxide (guideline-recommended combination).
Clinical Evidence
Risks & Side Effects
Initial retinoid reaction (dryness, peeling, erythema, burning) common in first 2-4 weeks, usually subsides by 4-6 weeks. Teratogenic - contraindicated in pregnancy. Photosensitivity requires sunscreen. Avoid eyes/mouth/mucosa. Moisturizer improves tolerability.
Interested in this treatment?
Start with an AI skin analysis to check your current skin condition